These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 9461114)

  • 1. Apolipoprotein AI and amyloidosis: a genetic model for aging.
    Benson MD
    Kidney Int; 1998 Feb; 53(2):508-9. PubMed ID: 9461114
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic familial amyloidosis caused by a new mutation in the apolipoprotein AI gene: clinical and pathological features.
    Caballería J; Bruguera M; Solé M; Campistol JM; Rodés J
    Am J Gastroenterol; 2001 Jun; 96(6):1872-6. PubMed ID: 11419842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial nephropathic systemic amyloidosis caused by apolipoprotein AI variant Arg26.
    Vigushin DM; Gough J; Allan D; Alguacil A; Penner B; Pettigrew NM; Quinonez G; Bernstein K; Booth SE; Booth DR
    Q J Med; 1994 Mar; 87(3):149-54. PubMed ID: 8208902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid cardiomyopathy associated with a novel apolipoprotein A-I Q172P variant.
    Vonberg FW; Gilbertson JA; Rowczenio D; Hutt DF; Rendell N; Taylor G; Hawkins PN; Gillmore JD
    Amyloid; 2015; 22(4):252-3. PubMed ID: 26469208
    [No Abstract]   [Full Text] [Related]  

  • 5. Familial nephropathic non-neuropathic amyloidosis: clinical features, immunohistochemistry and chemistry.
    Zalin AM; Jones S; Fitch NJ; Ramsden DB
    Q J Med; 1991 Nov; 81(295):945-56. PubMed ID: 1808634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Apolipoprotein A-I].
    Nakamura T; Tsujinaka K; Kashiwagi A
    Nihon Rinsho; 2001 Feb; 59 Suppl 2():96-100. PubMed ID: 11351710
    [No Abstract]   [Full Text] [Related]  

  • 7. Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein AI gene.
    Booth DR; Tan SY; Booth SE; Tennent GA; Hutchinson WL; Hsuan JJ; Totty NF; Truong O; Soutar AK; Hawkins PN; Bruguera M; Caballería J; Solé M; Campistol JM; Pepys MB
    J Clin Invest; 1996 Jun; 97(12):2714-21. PubMed ID: 8675681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new apolipoprotein Al variant, Trp50Arg, causes hereditary amyloidosis.
    Booth DR; Tan SY; Booth SE; Hsuan JJ; Totty NF; Nguyen O; Hutton T; Vigushin DM; Tennent GA; Hutchinson WL
    QJM; 1995 Oct; 88(10):695-702. PubMed ID: 7493166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Familial disseminated amylosis with cutaneous and cardiac predominance by apolipoprotein A1 mutation].
    Moulin G
    Ann Dermatol Venereol; 2000; 127(8-9):748. PubMed ID: 11011171
    [No Abstract]   [Full Text] [Related]  

  • 10. APOA1 related amyloidosis: a case report and literature review.
    Joy T; Wang J; Hahn A; Hegele RA
    Clin Biochem; 2003 Nov; 36(8):641-5. PubMed ID: 14636880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein AI and transthyretin as components of amyloid fibrils in a kindred with apoAI Leu178His amyloidosis.
    de Sousa MM; Vital C; Ostler D; Fernandes R; Pouget-Abadie J; Carles D; Saraiva MJ
    Am J Pathol; 2000 Jun; 156(6):1911-7. PubMed ID: 10854214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial amyloidosis--hereditary systemic disease of the connective tissue and other organs.
    Cohen AS; Steen L
    J Rheumatol; 1993 Jan; 20(1):4-6. PubMed ID: 8441163
    [No Abstract]   [Full Text] [Related]  

  • 13. Apolipoprotein 1 amyloidosis cardiomyopathy and the grey zone of non-invasive diagnostic algorithms: Red flags to reach the diagnosis.
    Plard L; Pallardy A; Trochu JN; Piriou N
    J Nucl Cardiol; 2021 Apr; 28(2):436-440. PubMed ID: 33629245
    [No Abstract]   [Full Text] [Related]  

  • 14. Colocalization of apolipoprotein AI in various kinds of systemic amyloidosis.
    Sakata N; Hoshii Y; Nakamura T; Kiyama M; Arai H; Omoto M; Morimatsu M; Ishihara T
    J Histochem Cytochem; 2005 Feb; 53(2):237-42. PubMed ID: 15684336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic analysis of murine senile amyloidosis.
    Naiki H; Higuchi K; Shimada A; Takeda T; Nakakuki K
    Lab Invest; 1993 Mar; 68(3):332-7. PubMed ID: 8095565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel apolipoprotein A-1 variant, Arg173Pro, associated with cardiac and cutaneous amyloidosis.
    Hamidi Asl K; Liepnieks JJ; Nakamura M; Parker F; Benson MD
    Biochem Biophys Res Commun; 1999 Apr; 257(2):584-8. PubMed ID: 10198255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Familial apolipoprotein A-I variants].
    Matsunaga A
    Nihon Rinsho; 1999 Dec; 57(12):2795-800. PubMed ID: 10638215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neuromuscular manifestations of amyloidosis.
    Simmons Z; Specht CS
    J Clin Neuromuscul Dis; 2010 Mar; 11(3):145-57. PubMed ID: 20215989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Livers from patients with apolipoprotein A-I amyloidosis are not suitable as "domino" donors.
    Shaz BH; Lewis WD; Skinner M; Khettry U
    Mod Pathol; 2001 Jun; 14(6):577-80. PubMed ID: 11406659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural diversity of ex vivo amyloid fibrils studied by cryo-electron microscopy.
    Jiménez JL; Tennent G; Pepys M; Saibil HR
    J Mol Biol; 2001 Aug; 311(2):241-7. PubMed ID: 11478857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.